Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    "fibrodysplasia ossificans progressiva" OR "Myositis Ossificans"
Show Display Options
Rank Status Study
1 Recruiting In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Intervention: Drug: Palovarotene
2 Recruiting The Fibrodysplasia Ossificans Progressiva (FOP) Connection Registry
Condition: Fibrodysplasia Ossificans Progressiva (FOP)
Intervention:
3 Recruiting A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
Condition: Fibrodysplasia Ossificans Progressiva
Intervention:
4 Recruiting An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene dose level 1;   Drug: Palovarotene dose level 2;   Drug: Palovarotene dose level 3
5 Active, not recruiting An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
Condition: Fibrodysplasia Ossificans Progressiva
Interventions: Drug: Palovarotene;   Drug: Placebo
6 Completed Urine Sample Collection From FOP Patients
Condition: Fibrodysplasia Ossificans Progressiva
Intervention:

Indicates status has not been verified in more than two years